From: A novel approach to treatment of hypertension in diabetic patients – a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 – rationale and design [ISRCTN55725285]
GoalBP*
Threshold
Upper limit
for all patients regardless BP values
for initiation of double-combination
of BP values targeted
< 130/80 mmHg
> 150/90 mmHg
≤ 179/109 mmHg